Toyota and Lexus Airbag Recall Includes Land Cruiser, 4Runner, Tundra, Sequoia, LX, and GX Models

Toyota Motor Sales, U.S.A., Inc. has initiated a safety recall affecting numerous Toyota and Lexus brand vehicles effective February 2nd, 2016. In total, 320,000 vehicles are affected by the recall and will require a repair at no additional cost to the vehicle owner.

The safety recall is due to a programming error in the side Curtain-Shield-Airbags (CSAs) control modules. CSAs are designed to deploy from the roof when certain conditions in an accident are met. However, the current programming can unexpectedly result in the deployment of CSAs and injure passengers in the vehicle.

Affected by this recall are the Model Year 2003-2006 Land Cruiser; 2004-2006 4Runner; 2005-2006 Tundra and Sequoia; 2003-2006 LX 470; and 2004-2006 GX 470 vehicles.

Though owners of these vehicles will be contacted via First Class Mail by Toyota or Lexus to schedule their free safety recall repair appointment, an alternative means to determine the status of a vehicle is to visit the Toyota Motor Sales recall website.

Vehicle owners are also invited to enter their Vehicle Identification Number (VIN) at the NHTSA Safe Car website for safety recall information at any time.

Possible Medication Switch Causes Recall

American Health Packaging is recalling many 600 mg ibuprofen tablets and a lot of the epilepsy drug, oxcarbazepine, in 300 mg tablets that were shipped. AmerisourceBergen issued the voluntary recall, because there is a chance that the two medications may have been switched in the blister packs.

The recall was issued over worries that the two drugs could be inadvertently administered to incorrect patients due to the mislabeled packaging. The problem was brought to American Health Packaging’s attention through a customer complaint. So far, no adverse reactions have been reported.

The ibuprofen tablets affected by the recall are from lot #142588 and have an expiration date of 01/2016. They are 600 mg and in a hospital unit dose presentation. They should not be taken because they may contain individual blistered doses labeled as oxcarbazepine tablets, 300 mg, lot #14544. The oxcarbazepine tablets affected by the recall are from lot #142544, and have an expiration date of 02/2016. They may contain the formerly identified lot of ibuprofen pills. These medications, intended for use at hospitals, were distributed across the United States starting June 20, 2014.

Drug Risks Posed by This Recall

Due to this packaging error, patients prescribed oxcarbazepine may be inadvertently given a dose of ibuprofen, and vice versa. Although no adverse reactions have yet been reported, taking the wrong medication could have serious negative consequences for hospital patients.

They also could develop serious complications from unexpected drug interactions.

The most serious risk, according to the company, is that patients who take the prescribed oxcarbazepine could miss a scheduled dose. As oxcarbazepine is a drug prescribed for epilepsy, even missing a single dose could cause a seizure. In fact, this risk was listed by American Health Packaging as the primary reason for the recall.

However, there are also risks in giving a patient ibuprofen when it is not prescribed. Although an over the counter drug is generally safe, ibuprofen can cause serious side effects when combined with certain drugs. Missing a dose of ibuprofen is generally not considered an emergency, as the medication is primarily used as an anti-inflammatory or mild pain reliever. However, not receiving a scheduled dose could cause a patient unnecessary pain.


Chrysler Recalls SUVs

Chrysler has recalled an estimated 792,000 vehicles for faulty ignition switches. The affected vehicles are all SUVs with model years ranging from 2005 to 2007. The specific models in question are Jeep Commanders from model years 2006-2007 and Jeep Grand Cherokees from 2005-2007.

When a person is driving the vehicles, they may bump their keys with a knee. In these particular models, a simple bump can have serious consequences. The ignition switch problem can cause the ignition key to move out of the “on” position while the car is being driven, causing the engine to stall. This can even also cause the front airbags to stop working.

So far, no injuries have been reported to the company related to this problem, but one accident has been linked to the issue. The company will continue to investigate if the issue has caused any other accidents. After this investigation and a full engineering review of models with this ignition switch, the exact number of recalled vehicles will be determined and affected customers will be contacted.

The investigation is expected to finish by mid-September of 2014. At this time, customers will be able to bring the affected SUVs to dealerships for repairs. In the meantime, Chrysler is urging customers to remove all other keys and items from key chains and to make sure to keep knees a safe distance from the ignition.

Recall Will Add to Millions of Vehicles Already Recalled for Faulty Ignition Switches

Problems with ignition switches have already caused millions of vehicles to be recalled in 2014. In June, Chrysler recalled 696,000 minivans and SUVs for a related issue. GM has similarly recalled over 14 million vehicles for faulty ignition switches in 2014.

The faulty ignition switches in the affected GM vehicles were made by major U.S. auto parts supplier Delphi. There are concerns that this issue may affect other cars supplied by the same company. It is still unknown if the Chrysler recall is caused by the same problem, as a spokesperson for the company would not say what company made the ignition switches in the recalled SUVs.

Chrysler has promised to get to the root of the problem as quickly as possible. The company has assured the public that newer models of the Jeep Grand Cherokee would not be affected by the same problem, because the vehicle has since been completely redesigned. The Jeep Commander is no longer being manufactured.


GlaxoSmithKline Recalls Improperly Child-Proofed Products

GlaxoSmithKline has voluntarily recalled four lots of Panadol Advance 100-count bottles in Puerto Rico. The recall for the pain relief medication was issued due to a lack of appropriate child-resistant packaging to protect against access by young children. Panadol Advance contains acetaminophen, which is required to be noted clearly on the label and given special packaging to avoid acetaminophen overdose or poisoning.

Panadol Advance bottles should always have child-resistant packaging or be labeled as a product “for households without young children,” yet the current packaging is not up to code.

The lots included in the recall are 14241, 14002, 13881, and 13801, with expiration dates of 02/2015, 10/2014, 09/2014, and 09/2014 respectively. The lot and expiration date of a particular bottle can be identified by looking on the left side of the label near the bar code. These lots could be bought exclusively at drug stores and retail establishments in Puerto Rico, so any products purchased within the mainland of the United States should not be affected.

The four lots include all of the current supply of this product in Puerto Rico. This means that Panadol Advance will be out of stock and off shelves until new shipments can be sent. “GSK regrets the inconvenience this issue may cause. We are working diligently to bring back to shelves the products our consumers trust and love,” said the company in a statement on its website.

Thus far, no injuries or related incidents have been reported, and the medication itself is still safe to use as directed. However, it is important to be vigilant against risk of unintentional ingestion and overdose.

Acetaminophen Poisoning Risks

The Food and Drug Administration (FDA) has given special attention to the risks of acetaminophen, which is easily found in more than 600 over-the-counter products. While an effective pain reliever in proper doses, taking too much of the medication can do serious health damage.

Acetaminophen toxicity has been a problem in the United States in recent years. Up to 80,000 people in the United States overdose on acetaminophen every year, according to the FDA. About 500 of these cases are fatal. The agency has pushed pharmaceutical companies to do more to warn consumers to be careful when taking these over-the-counter painkillers.

One important step to limit acetaminophen poisoning has been the requirement for child-safe packaging on all products containing the drug under the Poison Prevention Packaging Act enforced by the Consumer Product Safety Commission (CPSC).

Since the packaging of Panadol Advance does not meet the requirements of this act, the CPSC would have required a recall had the company not voluntarily removed the products. “Consumers should immediately place the product out of a child’s sight and reach, and contact GSK for a refund,” the CPSC said in a statement.

Customers can contact GSK toll-free at (888) 912-8455 from 9 a.m. to 5 p.m. ET Monday through Friday at their dedicated recall line in order to ask questions or find out how to get a refund.


Company Recalls Chicken Entrees

B. Roberts Foods, a Charlotte, North Carolina-based prepared foods company, has recalled over 200 pounds of individual, grilled chicken, pre-pared entrees due to misbranding and an undeclared allergen. The entrees contain milk, which is not declared on the product label and may be a concern for people, including those who are lactose intolerant.

The exact product in concern is their 10 oz. (248 g) pre-prepared, refrigerated packages of “Harris Teeter, Fresh Foods Market, Deli-Bakery, All Natural Grilled Chicken Strips (minimally processed, no artificial ingredients)” chicken entrees. The company did not state concerns for the health or safety of the product, but rather potential concerns related to food allergies caused by mislabeling the product.

The top label on the packaging incorrectly reads “All Natural Grilled Chicken Strips (minimally processed, no artificial ingredients), Net Wt 10 oz. (248g)” and the bottom label incorrectly reads “Grilled Chicken Breast with Lemon Spaghetti.” Both labels should actually read  “Grilled Chicken Breast with Sun-dried Tomato Pasta.”

These pre-pared chicken entrees were produced by B. Roberts Foods on July 10, 2014 and bear the company number “Est. 19198” inside the USDA mark of inspection with package code “50223.” They should have a sell-by date of 07/27/14.

The mislabeled “Grilled Chicken Breast with Sun-dried Tomato Pasta” entrees were distributed to retail supermarkets across the Southeast region in Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Tennessee, Washington D.C., and Virginia.

Causes and Effects of the Recall Incident

The labeling problem was originally discovered by an employee at a grocery store that sells the entrees. The employee noticed that the product was incorrectly labeled and reported the error to management.

The grocery store then reported the error to B. Roberts Foods. The company confirmed that the “Grilled Chicken Breast with Sun-dried Tomato Pasta” entrees were incorrectly labeled due to an employee error during the factory process. A recall was issued for the remaining products, and they were pulled from the shelves of the supermarkets that carried them.

So far, the company has received no reports of adverse reactions or any injuries caused by the mislabeled packaging. However, anyone who is concerned about a potential reaction should contact a healthcare provider.

For more information about the recall, concerned parties can go to the USDA Food Safety and Inspection Service (FSIS) website run by the USDA. The FSIS has a 24-hour virtual representative on hand to answer any recall questions and give advice about concerns related to this and other food product recalls.